Literature DB >> 2298243

Transcription switch of two phosphoglycerate kinase genes during spermatogenesis as determined with mouse testis sections in situ.

M Goto1, T Koji, K Mizuno, M Tamaru, S Koikeda, P K Nakane, N Mori, Y Masamune, Y Nakanishi.   

Abstract

In order to elucidate the mechanistic interpretations underlying differential expression of the two phosphoglycerate kinase (PGK) genes during mammalian spermatogenesis, localization of its mRNAs in mouse testis sections was determined by in situ hybridization. MRNA for nonsperm-type PGK-1 was identified in nongerminal Leydig and Sertoli cells, spermatogonia, and spermatocytes, but was not detected in spermatids. In contrast, mRNA for sperm-type PGK-2 was notable in leptotene spermatocytes, becoming most abundant in pachytene spermatocytes. It was amply present in spermatids only up to step 10, completely disappearing after step 12. It is possible to assume that a transcription switch of the two PGK genes ensued following the onset of meiosis. These findings taken together with previous observations indicate that differential expression of the two PGK genes during mammalian spermatogenesis is regulated at the transcriptional and post-transcriptional levels.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2298243     DOI: 10.1016/0014-4827(90)90306-u

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  14 in total

1.  Testis-specific expression of the human MYCL2 gene.

Authors:  N G Robertson; R J Pomponio; G L Mutter; C C Morton
Journal:  Nucleic Acids Res       Date:  1991-06-11       Impact factor: 16.971

2.  A novel Ca2+/calmodulin-dependent protein kinase and a male germ cell-specific calmodulin-binding protein are derived from the same gene.

Authors:  A R Means; F Cruzalegui; B LeMagueresse; D S Needleman; G R Slaughter; T Ono
Journal:  Mol Cell Biol       Date:  1991-08       Impact factor: 4.272

3.  Human testis expresses a specific poly(A)-binding protein.

Authors:  C Féral; G Guellaën; A Pawlak
Journal:  Nucleic Acids Res       Date:  2001-05-01       Impact factor: 16.971

4.  Transcription inhibition of the somatic-type phosphoglycerate kinase 1 gene in vitro by a testis-specific factor that recognizes a sequence similar to the binding site for Ets oncoproteins.

Authors:  M Goto; T Tamura; K Mikoshiba; Y Masamune; Y Nakanishi
Journal:  Nucleic Acids Res       Date:  1991-07-25       Impact factor: 16.971

5.  Molecular characterization of the porcine testis-specific phosphoglycerate kinase 2 (PGK2) gene and its association with male fertility.

Authors:  Kefei Chen; Christoph Knorr; Gerhard Moser; Kesinee Gatphayak; Bertram Brenig
Journal:  Mamm Genome       Date:  2004-12       Impact factor: 2.957

6.  Testis-specific mak protein kinase is expressed specifically in the meiotic phase in spermatogenesis and is associated with a 210-kilodalton cellular phosphoprotein.

Authors:  A Jinno; K Tanaka; H Matsushime; T Haneji; M Shibuya
Journal:  Mol Cell Biol       Date:  1993-07       Impact factor: 4.272

7.  A testis-specific gene encoding a nuclear high-mobility-group box protein located in elongating spermatids.

Authors:  G Boissonneault; Y F Lau
Journal:  Mol Cell Biol       Date:  1993-07       Impact factor: 4.272

8.  Spermatogenic cell-specific type 1 hexokinase is the predominant hexokinase in sperm.

Authors:  Noriko Nakamura; Haruna Shibata; Deborah A O'Brien; Chisato Mori; Edward M Eddy
Journal:  Mol Reprod Dev       Date:  2008-04       Impact factor: 2.609

9.  Direct effect of basic fibroblast growth factor on gene transcription in a cell-free system.

Authors:  Y Nakanishi; K Kihara; K Mizuno; Y Masamune; Y Yoshitake; K Nishikawa
Journal:  Proc Natl Acad Sci U S A       Date:  1992-06-15       Impact factor: 11.205

10.  Platelet derived growth factor and fibroblast growth factor basic levels in the vitreous of patients with vitreoretinal disorders.

Authors:  L Cassidy; P Barry; C Shaw; J Duffy; S Kennedy
Journal:  Br J Ophthalmol       Date:  1998-02       Impact factor: 4.638

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.